Loading clinical trials...

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

Effect of Hyperbaric Oxygen Therapy on Patients With Sudden Sensorineural Hearing Loss and Coagulation Function

NCT06819202•Sun Yuting

View on ClinicalTrials.gov

Summary

The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis. The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL. The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared

Eligibility

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Meet the diagnostic criteria for sudden deafness in the American Academy of Otolaryngology Head and Neck Surgery 2019 Clinical Practice Guidelines for Sudden Deafness;
•Aged 18-75 years old;
•Patients with unilateral sudden deafness for the first time, and the onset time is less than 2 weeks.

Exclusion Criteria

•Patients with other ear diseases, such as auditory trauma, barotrauma, retrocochlear disease, bilateral hearing loss, history of chronic otitis media in the same ear, and history of surgery in the same ear;
•Patients with serious primary diseases such as heart, liver, kidney dysfunction and hematopoietic system diseases;
•Pregnant and nursing patients;
•Accompanied by serious mental illness;
•Patients with incomplete clinical data.

Locations (1)

Shanghai University of Traditional Chinese Medicine

Shanghai, Putuo, China

Key Dates

Start Date

June 1, 2025

Primary Completion Date

June 1, 2025

Completion Date

December 1, 2025

Last Updated

May 14, 2025

Enrollment

1,309

ESTIMATED participants

Conditions

Sudden Sensorineural Hearing Loss (SSNHL)Hyperbaric Oxygen Therapy

Interventions

Hyperbaric oxygen treatment

OTHER

Contacts

Sun Yuting

CONTACT

+89 198 2175 8594 syt_354@163.com

Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections

NCT07120581

Invasive Fungal InfectionsHyperbaric Oxygen Therapy

View study

NOT_YET_RECRUITINGPHASE4

Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss

NCT06878599

Sudden Sensorineural Hearing Loss (SSNHL)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 14, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

Inclusion Criteria

Exclusion Criteria

Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections

Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss

Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial

Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)

Effect of Self-acupressure on Middle Ear Barotrauma Associated With Hyperbaric Oxygen Therapy

Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis